EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Eosinophil-derived COX-2 protects against experimental colitis through the PGE 2 –IL-22 axis

Yang Yang iD, Constance L Atkins, Yuanyuan Fan iD, Lidan Hou, Jie Zhao, Junda Gao iD, Yankai Wen iD, Nicolas F Moreno iD, Xiangsheng Huang, Faraz Bishehsari, Agnieszka K Czopik, Sean P Colgan iD und 5 weitere

Proceedings of the National Academy of Sciences · 2026

DOI: 10.1073/pnas.2525334123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2026. Verfasst von Yang Yang und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX 77030. Hauptthemen laut MEDLINE: Eosinophils, Cyclooxygenase 2, Interleukins, Colitis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: HHS | NIH | National Institute on Alcohol Abuse and Alcoholism (NIAAA), NHGRI NIH HHS, HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory bowel disease (IBD) is driven by a breakdown in immune regulation and epithelial barrier function, yet the contribution of eosinophils to this process has remained poorly defined and controversial. While eosinophils infiltrate the intestinal mucosa during both flares and remission, their role in shaping disease outcomes is unclear. Our RNA-seq analyses of colonic eosinophils isolated from dextran sulfate sodium (DSS)-treated mice revealed a significant upregulation of cyclooxygenase (COX)-2 (gene name, Ptgs2 ). Eosinophil-specific deletion of COX-2 (Ptgs2 fl/fl eoCre +/− ) reduced IL-22 production and exacerbated DSS- and trinitrobenzene sulfonic acid (TNBS)-induced colitis, characterized by greater weight loss, higher disease activity, colon shortening, and epithelial injury. Administration of recombinant IL-22 reversed these phenotypes. Mechanistically, eosinophil-derived COX-2 enhanced IL-22 production by type 3 Innate lymphoid cells (ILC3s) through prostaglandin E2 (PGE 2 ) signaling. Consistently, Ptgs2 fl/fl eoCre +/− mice exhibited reduced colonic PGE 2 levels, while PGE 2 analog treatment restored IL-22 production and mucosal protection. Our findings identify eosinophil-derived COX-2 and PGE 2 as a critical regulator of IL-22 production during colitis, uncovering a eosinophil–ILC3 cross talk that safeguards the intestinal barrier and represents a promising therapeutic target in IBD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EosinophilsCyclooxygenase 2InterleukinsColitisDinoprostoneAnimalsInterleukin-22MiceDextran SulfateIntestinal MucosaSignal TransductionMice, Inbred C57BLDisease Models, AnimalColon

Stichwörter der Autor:innen

IL-22eosinophilinflammatory bowel diseaseprostaglandin E2

Substanzen

Interleukin-22Cyclooxygenase 2InterleukinsDinoprostoneDextran SulfatePtgs2 protein, mouse

Autor:innen und Institutionen

  • Department of Anesthesiology, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX 77030.
  • Department of Internal Medicine, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX 77030.
  • Mucosal Inflammation Program, Division of Gastroenterology and Hepatology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045.
  • Division of Gastroenterology and Hepatology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611.
  • Division of Allergy, Asthma and Clinical Immunology, Mayo Clinic, Scottsdale, AZ 85259.

ORCID-Profile: Yang Yang, Yuanyuan Fan, Junda Gao, Yankai Wen, Nicolas F Moreno, Sean P Colgan, Tugrul Purnak, Keith C Summa, Yingzi Cong, Elizabeth A Jacobsen

Förderung

  • HHS | NIH | National Institute on Alcohol Abuse and Alcoholism (NIAAA)
  • NHGRI NIH HHS
  • HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
  • NIDDK NIH HHS
  • NIAAA NIH HHS
  • HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  • NIAID NIH HHS

Zitieren

APA

Yang, Y., Atkins, C. L., Fan, Y., Hou, L., Zhao, J., Gao, J., Wen, Y., Moreno, N. F., Huang, X., Bishehsari, F., Czopik, A. K., Colgan, S. P., Purnak, T., Summa, K. C., Cong, Y., Jacobsen, E. A., & Ju, C. (2026). Eosinophil-derived COX-2 protects against experimental colitis through the PGE 2 –IL-22 axis. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2525334123

Vancouver

Yang Y, Atkins CL, Fan Y, Hou L, Zhao J, Gao J, et al. Eosinophil-derived COX-2 protects against experimental colitis through the PGE 2 –IL-22 axis. Proceedings of the National Academy of Sciences. 2026. doi:10.1073/pnas.2525334123

BibTeX
@article{Yang2026,
  author = {Yang, Yang and Atkins, Constance L and Fan, Yuanyuan and Hou, Lidan and Zhao, Jie and Gao, Junda and Wen, Yankai and Moreno, Nicolas F and Huang, Xiangsheng and Bishehsari, Faraz and Czopik, Agnieszka K and Colgan, Sean P and Purnak, Tugrul and Summa, Keith C and Cong, Yingzi and Jacobsen, Elizabeth A and Ju, Cynthia},
  title = {Eosinophil-derived COX-2 protects against experimental colitis through the PGE 2 –IL-22 axis},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2026},
  doi = {10.1073/pnas.2525334123}
}
Kostenlos starten →